510(k) Report

510(k) · Cleared

Cleared

NEXA Negative Pressure Wound Therapy System

K162610510(k) TraditionalCleared Jun 8, 2017262-day reviewClass II21 CFR 878.4780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nexa Medical, Ltd. · OMP Negative Pressure Wound Therapy Powered Suction Pump

Cleared on Jun 8, 2017 as substantially equivalent to K132741 (Kci USA, Inc., 2013) after a 262-day review. Its family tree reaches back 6 generations to 1995.

Decided
Jun 8, 2017
Review
262 days
Class
Class II
Product code
OMP
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K945062 (1995). 10 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK945062 VacplusKinetic Concepts, Inc. · 1995
  2. 5 generations backK971548 AmbuvacKinetic Concepts, Inc. · 1997
  3. 4 generations backK032310 Mini V.a.C., V.a.C. Freedom, V.a.C. AtsKinetic Concepts, Inc. · 2003 · Recalled
  4. 3 generations backK063692 V.a.C. Therapy Systems-Acti V.a.C. Therapy Unit Model# 340000Kci USA, Inc. · 2007 · Recalled
  5. 2 generations backK093526 V.a.C. Via Therapy System, V.a.C. Via Negative Pressure Therapy…Kci USA, Inc. (Kinetic Concepts, Inc.) · 2010
  6. 1 generation backK132741 V.a.C. Via Negative Pressure Wound Therapy SystemKci USA, Inc. · 2013
  7. This deviceK162610 NEXA Negative Pressure Wound Therapy SystemNexa Medical, Ltd. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K945062VacplusKinetic Concepts, Inc.1995—
−5K971548AmbuvacKinetic Concepts, Inc.1997—
−4K032310Mini V.a.C., V.a.C. Freedom, V.a.C. AtsKinetic Concepts, Inc.20032
−3K063692V.a.C. Therapy Systems-Acti V.a.C. Therapy Unit Model# 340000Kci USA, Inc.20071
−2K093526V.a.C. Via Therapy System, V.a.C. Via Negative Pressure Therapy Unit, V.a.C.…Kci USA, Inc. (Kinetic Concepts, Inc.)2010—
−1K132741V.a.C. Via Negative Pressure Wound Therapy SystemKci USA, Inc.2013—
0 (this device)K162610NEXA Negative Pressure Wound Therapy SystemNexa Medical, Ltd.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010
200910
201010
201210
FIG. 1 — Lineage of K162610, 1995–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMP device

  1. #1 K260646 Renasys Edge (66803126)score 15.3 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K132741V.a.C. Via Negative Pressure Wound Therapy System
Summary page 5
…, Inc. (Kinetic Concepts, Inc). San Antonio, TX 78249, US Device Name V.A.C.® Via™ NPWT System FDA 510(k) No. K132741 Clearance given by FDA November 15th 2013 to market this device on FDA Device Classification Class II FDA Product Code…
Kci USA, Inc.2013—

Also cleared against K132741: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 4 companies; a new generation was cleared every 3.7 years on median.
  • 3 of the 10 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K132741.

How does its category compare?

All OMP devices

OMP Negative Pressure Wound Therapy Powered Suction Pump: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · OMP

5in 2025

2007: 62008: 82009: 82010: 62011: 62012: 112013: 112014: 102015: 202016: 192017: 112018: 132019: 152020: 62021: 92022: 102023: 82024: 92025: 52026 (partial year): 9
2007high 20 (2015) · low 5 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMP

127in 2025

2007: 113 days median2008: 98 days median2009: 87 days median2010: 97 days median2011: 123 days median2012: 292 days median2013: 84 days median2014: 179 days median2015: 189 days median2016: 146 days median2017: 137 days median2018: 214 days median2019: 249 days median2020: 179 days median2021: 238 days median2022: 229 days median2023: 291 days median2024: 181 days median2025: 127 days median2026 (partial year): 141 days median
2007high 292 (2012) · low 84 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMP

2in 2024

2009: 72010: 32012: 12013: 22014: 42015: 12016: 22019: 12024: 2
2007high 7 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OMP

140in 2025

2007: 12008: 12009: 792010: 802011: 1302012: 972013: 1692014: 2292015: 3782016: 3982017: 3682018: 4222019: 9942020: 3,6642021: 1,4222022: 2582023: 1432024: 1352025: 140
2007high 3,664 (2020) · low 1 (2007)2025

MAUDE reports naming product code OMP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611301
200889801
2009887779
2010697380
201161230130
201211292197
201311842169
2014101794229
2015201891378
2016191462398
2017111370368
2018132140422
2019152491994
2020617903,664
2021923801,422
2022102290258
202382910143
202491812135
202551270140
202691410—

What is it indicated for?

The NEXA NPWT system is intended for patients who may benefit from the application of negative pressure to the

wound to promote wound healing through the removal of excess exudate, infectious material and tissue debris.

It is intended for use in long-term care and acute settings only when prescribed by a Health Care Professional.

Appropriate wound types include:

• Chronic wounds

• Pressure ulcers

• Diabetic foot ulcers

• Venous leg ulcers

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K162610: NEXA Negative Pressure Wound Therapy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K162610

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026